| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-30 | NCT07848347 Dermal Acceptability Evaluation in Sensitive Skin | Recruiting | |
| 2026-09-30 | NCT07848555 Dermal and Ophthalmological Acceptability and Comedogenicity Assessment of a Cosmetic… | Recruiting | |
| 2026-09-24 | NCT07839104 Pediatric Acceptability Evaluation of a Cosmetic Product | Recruiting |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07712913 | Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With… | Diabetic Neuropathy | Recruiting | 2026-07-20 |
| NCT07626437 | Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg… | Common Cold/Flu | Recruiting | 2026-06-16 |
| Not applicable | ||||
| NCT07848347 | Dermal Acceptability Evaluation in Sensitive Skin | Sensitive Skin | Recruiting | 2026-09-30 |
| NCT07848555 | Dermal and Ophthalmological Acceptability and Comedogenicity Assessment of a Cosmetic… | Oily Skin | Recruiting | 2026-09-30 |
| NCT07839104 | Pediatric Acceptability Evaluation of a Cosmetic Product | Pediatric Safety | Recruiting | 2026-09-24 |
| NCT07768800 | Evaluation of Dermal Acceptability and Comedogenic and Acnegenic Potential of a Cosmetic… | Oily Skin | Recruiting | 2026-09-16 |
| NCT07769268 | Efficacy Evaluation of a Cosmetic Product for Facial Hyperpigmentation | Hyperpigmentation | Recruiting | 2026-09-16 |
| NCT07820943 | Dermatological Acceptability and Efficacy in Improving Xerosis, Skin Hydration, and… | Xerosis | Recruiting | 2026-09-16 |
| NCT07771998 | Dermal and Ophthalmological Acceptability Assessment in Sensitive Skin | Sensitive Skin | Recruiting | 2026-09-11 |
Diabetes (1)